Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
What is Cancer?02:12

What is Cancer?

10.7K
Cells and tissues must meticulously coordinate their activities for the normal functioning of the human body. Therefore, they exhibit socially responsible behavior - resting, growing, dividing, differentiating, or dying - for the organism’s benefit. Cancer arises when cells divide uncontrollably and invade other tissues or organs.
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
10.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Cancer Survival Analysis01:21

Cancer Survival Analysis

353
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
353
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
Cancer02:18

Cancer

48.5K
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.
48.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Targeted cancer therapy: the initial high concentration may slow down the selection for resistance.

Aging·2024
Same author

From osimertinib to preemptive combinations.

Oncotarget·2024
Same author

Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?

Aging·2023
Same author

Evaluation of off-label rapamycin use to promote healthspan in 333 adults.

GeroScience·2023
Same author

Apoptotic cell death in disease-Current understanding of the NCCD 2023.

Cell death and differentiation·2023
Same author

Cancer prevention with rapamycin.

Oncotarget·2023
Same journal

The dual axis of tumorigenesis: MAPK and PI3K/AKT pathways in papillary thyroid carcinoma.

Oncoscience·2026
Same journal

Adaptor proteins regulating tumor-associated macrophage polarization during cancer progression.

Oncoscience·2026
Same journal

Unprecedented non-luminal esophageal adenocarcinoma invading the spine.

Oncoscience·2026
Same journal

Cervical angioleiomyoma: A rare tumor behind persistent menorrhagia and pelvic pain.

Oncoscience·2026
Same journal

Cultural carcinogens in oral squamous cell carcinoma risk across global populations.

Oncoscience·2026
Same journal

Enhancing breast cancer detection with AI for early diagnosis and recurrence prediction.

Oncoscience·2026
See all related articles

Related Experiment Video

Updated: Jul 6, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.0K

My battle with cancer. Part 1.

Mikhail V Blagosklonny1

  • 1Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.

Oncoscience
|January 8, 2024
PubMed
Summary
This summary is machine-generated.

Metastatic cancer remains incurable with sequential targeted therapies. However, preemptive combination treatments offer theoretical curative potential for advanced lung cancer. This personal journey explores treatment strategies.

Keywords:
METbrain metastasescapmatiniblung cancerresistance

More Related Videos

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
05:42

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies

Published on: August 11, 2023

1.1K
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

2.9K

Related Experiment Videos

Last Updated: Jul 6, 2025

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer
08:26

Author Spotlight: Advancing Personalized Medicine in Ovarian Cancer

Published on: February 23, 2024

2.0K
Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies
05:42

Author Spotlight: Unlocking the Mysteries of Oral Potential Malignancies

Published on: August 11, 2023

1.1K
Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors
05:58

Author Spotlight: Exploring Strategies for Successful Immune Response Against Tumors

Published on: August 16, 2024

2.9K

Area of Science:

  • Oncology
  • Cancer Therapeutics
  • Translational Medicine

Background:

  • The patient was diagnosed with numerous brain metastases from lung cancer in January 2023.
  • This diagnosis prompted a mission to investigate curative-intent treatments for metastatic cancer.

Purpose of the Study:

  • To argue that sequential monotherapy with targeted drugs cannot cure metastatic cancer.
  • To propose that preemptive combinations of targeted drugs may theoretically cure metastatic cancer.
  • To share personal insights on cancer treatment, including the role of rapamycin.

Main Methods:

  • The study presents a theoretical argument based on the author's personal experience and understanding of cancer biology.
  • It reviews the limitations of monotherapy and the potential of combination therapies.
  • Personal insights on rapamycin's effect on cancer and aging are discussed.

Main Results:

  • Sequential targeted drug therapy, even when administered in sequence, is unlikely to achieve a cure for metastatic cancer.
  • Preemptive combination therapy with targeted drugs presents a theoretical possibility for curing metastatic cancer.
  • Rapamycin, an anti-aging drug, can delay but not prevent cancer progression.

Conclusions:

  • Monotherapy approaches are insufficient for curing metastatic lung cancer.
  • Combination targeted drug strategies, applied preemptively, hold theoretical promise for curative treatment.
  • Further research into combination therapies is warranted to explore curative potential for metastatic cancers.